CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-21 | Springate Wayne S. Sr VP of Operations | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-21 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-21 | KIANI IRAJ EQHBAL Director | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-21 | Rodino Peter W. III Director | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-21 | MITCHELL WILLIAM M Director | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-15 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +24,203 | $0.11 | $3K | 24,203 |
| 2016-06-15 | Springate Wayne S. Sr VP of Operations | Grant or award · Incentive Rights | +15,206 | $0.11 | $2K | 15,206 |
| 2016-06-15 | Pascale Adam CFO | Grant or award · Incentive Rights | +15,455 | $0.11 | $2K | 15,455 |
| 2016-06-15 | Rodino Peter W. III Director | Grant or award · Incentive Rights | +13,823 | $0.11 | $2K | 13,823 |
| 2016-06-15 | MITCHELL WILLIAM M Director | Grant or award · Incentive Rights | +13,823 | $0.11 | $2K | 13,823 |
| 2016-06-15 | KIANI IRAJ EQHBAL Director | Grant or award · Incentive Rights | +13,823 | $0.11 | $2K | 13,823 |
| 2016-06-08 | Equels Thomas K. CEO / President | Other acquisition · Options to buy Common Stock | +300,000 | 2,350,000 | ||
| 2016-05-31 | Rodino Peter W. III Director | Grant or award · Incentive Rights | +12,671 | $0.12 | $2K | 12,671 |
| 2016-05-31 | MITCHELL WILLIAM M Director | Grant or award · Incentive Rights | +12,671 | $0.12 | $2K | 12,671 |
| 2016-05-31 | KIANI IRAJ EQHBAL Director | Grant or award · Incentive Rights | +12,671 | $0.12 | $2K | 12,671 |
| 2016-05-31 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +22,186 | $0.12 | $3K | 22,186 |
| 2016-05-31 | Springate Wayne S. Sr VP of Operations | Grant or award · Incentive Rights | +13,939 | $0.12 | $2K | 13,939 |
| 2016-05-31 | Pascale Adam CFO | Grant or award · Incentive Rights | +14,167 | $0.12 | $2K | 14,167 |
| 2016-05-15 | Rodino Peter W. III Director | Grant or award · Incentive Rights | +13,823 | $0.11 | $2K | 13,823 |
| 2016-05-15 | MITCHELL WILLIAM M Director | Grant or award · Incentive Rights | +13,823 | $0.11 | $2K | 13,823 |
Page 21 of 26 · 508 trades